Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Sponsor: argenx
Summary
The main purpose of this study is to compare empasiprubart and IVIg for treating people with CIDP. This study consists of a Part A where participants will either receive empasiprubart and a placebo resembling IVIg, or IVIg and a placebo resembling empasiprubart for 24 weeks (6 months). Following Part A, participants will enter Part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emvigorate
Official title: A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
218
Start Date
2025-08-22
Completion Date
2030-09
Last Updated
2026-03-06
Healthy Volunteers
No
Conditions
Interventions
empasiprubart
Intravenous infusion of empasiprubart
IVIg
Intravenous infusion of IVIg
empasiprubart-placebo
A placebo resembling the empasiprubart treatment
IVIg-placebo
A placebo resembling the IVIg treatment
Locations (46)
Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
Homestead Associates in Research Inc
Homestead, Florida, United States
Visionary Investigators Network
Miami, Florida, United States
Paradigm Health System
Slidell, Louisiana, United States
Erlanger Health System
Columbia, Maryland, United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
NeuroCarePlus
Houston, Texas, United States
National Neuromuscular Research Institute
Irving, Texas, United States
Fakultni nemocnice Brno
Brno, Czechia
Astra Kliinik
Tallinn, Estonia
Tartu University Hospital
Tartu, Estonia
Charité - Universitätsmedizin Berlin
Berlin, Germany
University General Hospital ''ATTIKON'' - General Hospital of West Attica H AGIA VARVARA
Chaïdári, Greece
The Barzilai University Medical Center
Ashkelon, Israel
Hadassah Medical Center- Ein Kerem
Jerusalem, Israel
The Chaim Sheba Medical Center
Tel Litwinsky, Israel
AUSL di Bologna - Ospedale Bellaria
Bologna, Italy
Aomori Prefectural Central Hospital
Aomori, Japan
Juntendo University Hospital
Bunkyō City, Japan
Chiba University Hospital
Chūōku, Japan
Osaka Metropolitan University Hospital
Osaka, Japan
Saga University Hospital
Saga, Japan
General Hospital Tsuchiura Kyodo Hospital
Tsuchiura, Japan
Yamaguchi University Hospital
Ube, Japan
MICS Centrum Medyczne Bydgoszcz
Bydgoszcz, Poland
Neurocentrum Bydgoszcz
Bydgoszcz, Poland
Centrum Medyczne Neurologia Slaska
Katowice, Poland
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Poland
Centrum Medyczne Linden
Krakow, Poland
Clinical Research Center Sp. z o.o. Medic-R sp.k.
Poznan, Poland
Centrum Medyczne Medyk
Rzeszów, Poland
Uniwersytecki Szpital Kliniczny Nr 1
Szczecin, Poland
ULS de Santo António, EPE - Hospital de Santo António
Porto, Portugal
Institutul National de Neurologie si Boli Neurovasculare Bucuresti
Bucharest, Romania
Brainaxy Clinic SRL
Constanța, Romania
Targu-Mures Emergency Clinical County Hospital
Târgu Mureş, Romania
Univerzitna nemocnica MARTIN
Martin, Slovakia
Inje University Haeundae Paik Hospital
Busan, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital Yonsei University Health System
Seoul, South Korea
Konkuk University Medical Center
Seoul, South Korea
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Universitario Vall d'Hebron
Sant Andreu de la Barca, Spain
Hôpitaux Universitaires de Genève (HUG)
Geneva, Switzerland